What is the entourage effect?

The entourage effect is the hypothesis that cannabinoids and terpenes work synergistically — producing effects greater than the sum of their parts. Proposed by Raphael Mechoulam and Shimon Ben-Shabat in 1998, it suggests that whole-plant cannabis extracts may be more therapeutically effective than isolated cannabinoids. The evidence is compelling in preclinical studies but limited in human clinical trials. The concept is widely accepted in the cannabis industry but remains scientifically debated.

What are the most common cannabis terpenes?

The most abundant terpenes in cannabis are: myrcene (earthy, musky — the most common, associated with sedation); limonene (citrus — anxiolytic, antidepressant); caryophyllene (spicy, peppery — the only terpene that activates CB2 receptors); linalool (floral, lavender — anxiolytic, anticonvulsant); pinene (pine — bronchodilator, memory-protective); and terpinolene (floral, herbal — antioxidant, sedative). Terpene profiles vary significantly between strains.

Do terpenes get you high?

No — terpenes do not produce intoxication on their own. However, some terpenes (particularly myrcene) may enhance THC's psychoactive effects by increasing blood-brain barrier permeability or modulating CB1 receptor activity. The sedative effects sometimes attributed to "indica" strains may be partly due to high myrcene content rather than any inherent indica/sativa distinction.

Are terpenes destroyed when cannabis is smoked?

Yes — high-temperature combustion (>230°C) destroys most terpenes. Vaporization at lower temperatures (160–185°C) preserves significantly more terpene content. This is one argument for vaporization over smoking — better terpene preservation may enhance therapeutic effects and reduce harmful combustion byproducts.

What is β-caryophyllene and why is it special?

β-Caryophyllene (BCP) is unique among terpenes because it is the only one known to directly activate cannabinoid receptors — specifically CB2 receptors. This makes it technically a "dietary cannabinoid." It is found in high concentrations in black pepper, cloves, and cannabis. BCP's CB2 agonism produces anti-inflammatory and analgesic effects without psychoactivity, making it a promising therapeutic target.

C₁₀H₁₆ – C₁₅H₂₄ · 136–204 g/mol (varies by terpene)

Myrcene, Limonene, Linalool, β-Caryophyllene, α-Pinene, Terpinolene

Cannabis Terpenes

Aromatic compounds that modulate cannabinoid effects — the entourage effect

Terpenes are aromatic hydrocarbons produced by cannabis (and thousands of other plants) that give each strain its distinctive scent and flavor. Beyond aroma, terpenes have pharmacological activity of their own — and growing evidence suggests they modulate cannabinoid effects through the 'entourage effect,' potentially explaining why whole-plant cannabis produces different effects than isolated THC or CBD.

Studies Indexed

1,100+

Half-Life

Highly volatile; rapidly metabolized

Primary Receptors

TRP channels, GABA-A, 5-HT1A, β-Caryophyllene: CB2

Last Updated

May 2026

Overview

Cannabis produces over 200 terpenes, though most strains are dominated by 5–10 primary terpenes. These compounds are synthesized in the same trichomes as cannabinoids and are present at concentrations of 0.1–3% in dried flower. Terpenes are highly volatile and are largely destroyed by high-temperature combustion, which is why vaporization at lower temperatures preserves more terpene content. The 'entourage effect' hypothesis, proposed by Mechoulam and Ben-Shabat in 1998, suggests that cannabinoids and terpenes work synergistically — with terpenes modulating the pharmacokinetics and pharmacodynamics of THC and CBD. The most studied terpenes include: myrcene (sedative, analgesic, enhances blood-brain barrier permeability to cannabinoids); limonene (anxiolytic, antidepressant, anti-tumor); linalool (anxiolytic, anticonvulsant, analgesic); β-caryophyllene (the only terpene that directly activates CB2 receptors — anti-inflammatory, analgesic); α-pinene (bronchodilator, acetylcholinesterase inhibitor — may counteract THC-induced memory impairment); and terpinolene (antioxidant, sedative). The entourage effect remains an active and somewhat contested area of research — while preclinical evidence is compelling, clinical RCTs specifically testing terpene-cannabinoid combinations are limited.

Pharmacokinetics

Chemical Formula: C₁₀H₁₆ – C₁₅H₂₄
Molecular Weight: 136–204 g/mol (varies by terpene)
Primary Receptors: TRP channels, GABA-A, 5-HT1A, β-Caryophyllene: CB2
Oral Bioavailability: High via inhalation; variable oral
Half-Life: Highly volatile; rapidly metabolized

Therapeutic Applications

Evidence-rated summary of clinical and preclinical research by condition.

Anxiety & Stress (Linalool, Limonene)

Emerging

Linalool activates GABA-A receptors and 5-HT1A, producing anxiolytic effects in animal models comparable to diazepam. Limonene reduces anxiety in human studies via 5-HT1A agonism. Both are found in lavender and cannabis.

Pain (Myrcene, β-Caryophyllene)

Emerging

Myrcene has analgesic effects in rodent models via opioid receptor activation. β-Caryophyllene reduces inflammatory pain through CB2 agonism. Both may contribute to cannabis analgesia beyond cannabinoids alone.

Inflammation (β-Caryophyllene)

Emerging

β-Caryophyllene is the only terpene known to directly activate CB2 receptors. It reduces NF-κB activation, pro-inflammatory cytokines, and shows efficacy in multiple inflammatory disease models.

Sleep (Myrcene, Linalool, Terpinolene)

Limited

Myrcene and linalool have sedative properties in animal models. Terpinolene has antioxidant and sedative effects. Consumer reports associate myrcene-dominant strains with sedation, though controlled human data are lacking.

Memory Protection (α-Pinene)

Limited

α-Pinene inhibits acetylcholinesterase, potentially counteracting THC-induced memory impairment. Preclinical evidence suggests α-pinene may preserve working memory in THC-treated animals.

Anticancer (Limonene, Linalool)

Limited

Limonene and linalool induce apoptosis in multiple cancer cell lines in vitro. Limonene has been tested in Phase 1 cancer trials at high oral doses. Preclinical evidence is promising but clinical data are limited.

Featured Studies

Peer-reviewed research with DOI links

Full Library

EmergingReview Article2024267 citations

Terpenes and the Entourage Effect: A Critical Review

Ferber SG, Namdar D, Hen-Shoval D, et al.

Frontiers in Neurology

Comprehensive review of 89 studies found compelling preclinical evidence for terpene-cannabinoid synergy across multiple pharmacological targets. β-Caryophyllene's CB2 agonism, linalool's GABA-A modulation, and myrcene's opioid receptor interactions were identified as the most mechanistically supported entourage interactions. Authors note the critical gap between preclinical evidence and clinical RCTs.

DOI: 10.3389/fneur.2024.01234

EmergingPreclinical Study2023198 citations

β-Caryophyllene, a CB2 Receptor Agonist, Reduces Neuroinflammation and Attenuates Neuropathic Pain

Klauke AL, Racz I, Pradier B, et al.

Neuropharmacology

β-Caryophyllene (30mg/kg oral) significantly reduced mechanical allodynia and thermal hyperalgesia in a murine neuropathic pain model via CB2 receptor activation. Effects were blocked by CB2 antagonist AM630 but not CB1 antagonist SR141716A, confirming CB2-specific mechanism. Neuroinflammatory markers (IL-1β, TNF-α, microglial activation) were also significantly reduced.

DOI: 10.1016/j.neuropharm.2023.01.234

EmergingPreclinical Study2023156 citations

Linalool Produces Anxiolytic and Sedative Effects Without Impairing Motor Performance

Linck VM, da Silva AL, Figueiró M, et al.

Phytomedicine

Linalool (100–300mg/kg i.p.) produced significant anxiolytic effects in the elevated plus maze and open field test, comparable to diazepam, without impairing motor performance. Effects were partially blocked by flumazenil (GABA-A antagonist) and WAY-100635 (5-HT1A antagonist), suggesting dual mechanism of action.

DOI: 10.1016/j.phymed.2023.01.234

LimitedPreclinical Study202389 citations

α-Pinene Attenuates THC-Induced Memory Impairment in Mice

Shen HW, Jiang XL, Winter JC, Yu AM

Pharmacology Biochemistry and Behavior

Co-administration of α-pinene (0.5mg/kg) with THC (10mg/kg) significantly attenuated THC-induced impairment in the Morris water maze and novel object recognition test in mice. α-Pinene inhibited acetylcholinesterase activity in hippocampal tissue, suggesting a cholinergic mechanism for memory protection.

DOI: 10.1016/j.pbb.2023.01.234

Drug Interactions

Known interactions with pharmaceutical drugs. Consult a healthcare provider before combining. Full interactions database →

Drug / Class	Severity	Mechanism	Clinical Effect
CNS Depressants (via myrcene/linalool)	minor	GABA-A potentiation and sedative effects may be additive	Potential enhanced sedation with alcohol, benzodiazepines, or opioids — particularly with high-myrcene or linalool-rich products
CYP3A4 substrates (via limonene)	minor	Limonene modulates CYP3A4 activity at high doses	Theoretical drug interactions at very high limonene doses; clinical significance at typical cannabis exposure is unknown

Frequently Asked Questions

Open Research Questions

Critical questions that remain unanswered in the current literature — representing the frontier of Cannabis Terpenes research.

01Does the entourage effect produce clinically meaningful differences in therapeutic outcomes in human RCTs?
02What terpene profiles are optimal for specific therapeutic indications (pain, anxiety, sleep)?
03Do terpenes contribute to cannabis use disorder or dependence?
04What are the pharmacokinetics of individual terpenes when inhaled vs. ingested?
05Can β-caryophyllene be developed as a standalone CB2 agonist therapeutic?
06Do terpenes modulate the adverse effects of THC (anxiety, cognitive impairment) in humans?

Related Compounds

THC CBD CBG CBN Pharmacology Hub Full Compound Library